[1] |
Bauer TM, Follo A, Navasa M, et al.Daily norfloxacin is more effective than weekly rufloxacin in prevention of spontaneous bacterial peritonitis recurrence. Dig Dis Sci, 2002, 47: 1356-1361.
|
[2] |
陈竹,曾义岚,王丽,等.乙型肝炎肝硬化并自发性细菌性腹膜炎的病原学及耐药性分析.中华实验和临床感染病杂志(电子版),2018,12:553-558.
|
[3] |
刘玉玲,冯振清,贾秋龙,等.乙型肝炎肝硬化并发自发性细菌性腹膜炎患者的血清白蛋白和肝纤维化指标的变化,实用肝脏病杂志,2017,20:356-357.
|
[4] |
余静,易斌,冯佳,等.酒精性肝病危险因素研究进展.胃肠病学和肝病学杂志, 2016, 25: 112-114.
|
[5] |
中华医学会肝病学分会脂肪肝和酒精性肝病学组,中国医师协会脂肪性肝病专家委员会.酒精性肝病防治指南( 2018 年更新版).临床肝胆病杂志,2018,34: 939-946.
|
[6] |
周永莉,段志军.肝炎后肝硬化与酒精性肝硬化患者临床特征的比较及防治.世界华人消化杂志,2010,18:3313-3319.
|
[7] |
吴真真. 酒精性肝硬化和肝炎后肝硬化的临床特点分析.临床医药文献电子杂志, 2019, 6:73.
|
[8] |
中华医学会肝病学分会.肝硬化腹水及相关并发症的诊疗指南(2017,北京).中华胃肠内镜电子杂志,2018,5:1-17.
|
[9] |
Mathurin P, O'Grady J, Carithers RL, et al. Corticosteroids improve short-term survival in patients with severe alcoholic hepatitis: meta-analysis of individual patient data. Gut, 2011, 60: 255-260.
|
[10] |
黄开利. 自发性细菌性腹膜炎的诊断和治疗.肝脏,2018,23:1034-1036.
|
[11] |
Floreani A.Liver diseases in the elderly: an update. Dig Dis, 2007, 25:138-143.
|
[12] |
刘晓红. 美国肝病学会关于“肝硬化腹水伴自发性细菌性腹膜炎”的实践指南.中国实用内科杂志,2007,27:565-567.
|
[13] |
郑林,陈亮,詹志刚.肝硬化合并自发性细菌性腹膜炎的危险因素及预后分析.临床军医杂志,2013,41:857-859.
|
[14] |
张驰豪,罗蒙.肝肾综合征发病机制的研究进展.肝胆胰外科杂志,2016,28:343-345.
|
[15] |
Poca M, Alvarado-Tapias E, Concepción M, et al.Predictive model of mortality in patients with spontaneous bacterial peritonitis. Aliment Pharmacol Ther, 2016, 44: 629-637.
|
[16] |
Huina Ren, Junna Wang, Yue Gao, et al.Metabolic syndrome and liver-related events: a systematic review and meta-analysis. BMC Endocrine Disorders, 2019, 19: 40.
|
[17] |
Italian Association for the Study of the Liver (AISF), Italian Society of Transfusion Medicine and Immunohaematology(SIMTI). AISF-SIMTI position paper: the appropriate use of albumin in patients with liver cirrhosis. Dig Liver Dis, 2016, 48: 4-15.
|